Hui Li is the founder of Adcentrx Therapeutics. Adcentrx Therapeutics has raised $88M in total funding. Latest round: Series A.
Hui Li is the Founder, President, and CEO of Adcentrx Therapeutics, a clinical-stage biotechnology company focused on advancing protein conjugates for cancer treatment. He led the company through its emergence with a $50 million Series A round in 2021 and a subsequent $38 million Series A+ round in 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library